Direct stimulation of de novo nucleotide synthesis by O-GlcNAcylation.

[1]  R. Deberardinis,et al.  De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma , 2022, Cancer cell.

[2]  T. Horvath,et al.  Ventromedial hypothalamic OGT drives adipose tissue lipolysis and curbs obesity , 2022, Science advances.

[3]  R. Zhou,et al.  O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1 , 2022, Nature Chemical Biology.

[4]  J. Quispe,et al.  Human PRPS1 filaments stabilize allosteric sites to regulate activity , 2022, bioRxiv.

[5]  Huadong Pei,et al.  De novo nucleotide biosynthetic pathway and cancer , 2022, Genes & diseases.

[6]  A. Burlingame,et al.  Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C. , 2022, Immunity.

[7]  N. Pavlova,et al.  The hallmarks of cancer metabolism: Still emerging. , 2022, Cell metabolism.

[8]  Zhaohui S. Qin,et al.  UALCAN: An update to the integrated cancer data analysis platform , 2022, Neoplasia.

[9]  Qianming Chen,et al.  Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair. , 2021, Cell metabolism.

[10]  F. He,et al.  Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation. , 2021, Molecular cell.

[11]  Alexandria K. D’Souza,et al.  Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase , 2021, Nature Chemical Biology.

[12]  I. Ben-Sahra,et al.  NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia , 2021, Science Advances.

[13]  A. Carnero,et al.  NAD+ metabolism, stemness, the immune response, and cancer , 2021, Signal Transduction and Targeted Therapy.

[14]  A. V. van Kuilenburg,et al.  Atypical presentation of Arts syndrome due to a novel hemizygous loss-of-function variant in the PRPS1 gene , 2020, Molecular genetics and metabolism reports.

[15]  A. Munnich,et al.  PRPS1 loss-of-function variants, from isolated hearing loss to severe congenital encephalopathy: New cases and literature review. , 2020, European journal of medical genetics.

[16]  Jianhua Zhang,et al.  Role of O-Linked N-acetylglucosamine (O-GlcNAc) Protein Modification in Cellular (Patho)Physiology. , 2020, Physiological reviews.

[17]  G. Hart,et al.  Targeting O-GlcNAcylation to develop novel therapeutics. , 2020, Molecular aspects of medicine.

[18]  E. Kwon,et al.  PRPS-Associated Disorders and the Drosophila Model of Arts Syndrome , 2020, International journal of molecular sciences.

[19]  H. Ju,et al.  O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth , 2020, Nature Communications.

[20]  M. Reginato,et al.  Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer , 2019, BMC Biology.

[21]  C. Thompson,et al.  Metabolic regulation of cell growth and proliferation , 2019, Nature Reviews Molecular Cell Biology.

[22]  J. Novak,et al.  Glycosylation in health and disease , 2019, Nature Reviews Nephrology.

[23]  L. Aravind,et al.  O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect , 2017, Proceedings of the National Academy of Sciences.

[24]  C. Peng,et al.  Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation. , 2017, Molecular cell.

[25]  Lin Chao,et al.  PRPS1 silencing reverses cisplatin resistance in human breast cancer cells. , 2017, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[26]  Xiaoyong Yang,et al.  Protein O-GlcNAcylation: emerging mechanisms and functions , 2017, Nature Reviews Molecular Cell Biology.

[27]  N. Hay,et al.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? , 2016, Nature Reviews Cancer.

[28]  A. Kallies,et al.  Glucose- and glutamine-fueled stabilization of C-Myc is required for T-cell proliferation and malignant transformation , 2016, Cell Death Discovery.

[29]  D. Hawke,et al.  A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation , 2016, Nature Cell Biology.

[30]  W. Guo,et al.  Deubiquitination and Activation of AMPK by USP10. , 2016, Molecular cell.

[31]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[32]  W. Guo,et al.  MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells. , 2015, Gastroenterology.

[33]  P. Wang,et al.  O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth , 2015, Nature Communications.

[34]  X. Liu,et al.  Association of PRPS1 Mutations with Disease Phenotypes , 2015, Disease markers.

[35]  A. Ferrando,et al.  Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL , 2015, Nature Medicine.

[36]  Zhiyong Zhang,et al.  Crystal and EM Structures of Human Phosphoribosyl Pyrophosphate Synthase I (PRS1) Provide Novel Insights into the Disease-Associated Mutations , 2015, PloS one.

[37]  G. Hart,et al.  Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. , 2014, Cell metabolism.

[38]  D. Sabatini,et al.  Regulation of mTORC1 by amino acids. , 2014, Trends in cell biology.

[39]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[40]  S. Scherer,et al.  Prenatal growth restriction, retinal dystrophy, diabetes insipidus and white matter disease: expanding the spectrum of PRPS1-related disorders , 2014, European Journal of Human Genetics.

[41]  Liewei Wang,et al.  AMPK regulates histone H2B O-GlcNAcylation , 2014, Nucleic acids research.

[42]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[43]  B. Manning,et al.  Signal integration by mTORC1 coordinates nutrient input with biosynthetic output , 2013, Nature Cell Biology.

[44]  Linda C Hsieh-Wilson,et al.  Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism , 2012, Science.

[45]  J. Hanover,et al.  Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation , 2012, Nature Reviews Molecular Cell Biology.

[46]  Gerald W. Hart,et al.  O-GlcNAc signalling: implications for cancer cell biology , 2011, Nature Reviews Cancer.

[47]  S. Nabuurs,et al.  PRPS1 mutations: four distinct syndromes and potential treatment. , 2010, American journal of human genetics.

[48]  M. Egmont-Petersen,et al.  Arts syndrome is caused by loss-of-function mutations in PRPS1. , 2007, American journal of human genetics.